ONCT - Oncternal Therapeutics Inc
IEX Last Trade
4.27
0.160 3.747%
Share volume: 3,096
Last Updated: Fri 30 Aug 2024 09:57:48 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$4.11
0.16
3.89%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-09 | 2022-11-03 | 2023-03-09 | 2023-05-04 | 2023-08-10 | 2023-11-09 | 2024-03-07 | 2024-05-09 | |
| Cash flow financing | 3.871 M | 3.694 M | 2.014 M | 1.119 M | -1.000 K | -49.000 K | -1.000 K | -87.000 K | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash flow | -7.130 M | -11.966 M | -9.002 M | -10.969 M | -9.263 M | -5.513 M | -6.419 M | -7.438 M | |
| Net income | -11.741 M | -11.125 M | -11.400 M | -11.487 M | -8.966 M | -9.862 M | -9.164 M | -8.388 M | |
| Depreciation | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 226.000 K | 0.000 | 282.000 K | 262.000 K | 186.000 K | 0.000 | 578.000 K | |
| Investing Cashflow | 0.000 | 0.000 | -26.498 M | -16.048 M | 13.852 M | 4.655 M | -1.808 M | 7.224 M | |
| Net Borrowings | -80.980 M | -74.564 M | -67.290 M | -57.635 M | -49.813 M | -42.306 M | -36.059 M | -27.926 M | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash Change | 78.900 M | 70.628 M | 63.724 M | 54.317 M | 45.503 M | 40.305 M | 34.255 M | 27.027 M |